ITMCTR2000003002
Recruiting
Phase 1
A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy
Huangshi Hospital of Traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- severe novel coronavirus pneumonia (COVID-19)
- Sponsor
- Huangshi Hospital of Traditional Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Hospitalized patients with novel coronavirus pneumonia confirmed by pathogenic detection
- •2\. Meet any one of the criteria for severe type:
- •1\) Respiratory distress: RP \>\= 30/min;
- •2\) At rest, the oxygen saturation \<\= 93%;
- •3\) Arterial partial pressure of oxygen (PaO2\)/Fraction of inspiration (FiO2\)(Oxygenation Index, P/F) \<\= 300mmHg.
- •3\. Aged 18 to 75 years;
- •4\. Signed informed consent.
Exclusion Criteria
- •1\. Pregancy or lactating women;
- •2\. People with allergies or allergies to components of Truncated Torsion formula;
- •3\. Patients with serious basic diseases such as malignant tumor, cirrhosis, chronic renal failure (uremic stage), hematological disease, HIV, etc.;
- •4\. Patients with obstructive pneumonia caused by lung tumor, pulmonary fibrosis, alveolar proteinosis and allergic alveolitis;
- •5\. Patients with long\-term use of hormone, immunosuppressant and other drugs;
- •6\. Severe mental illness or inability to cooperate with investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategyITMCTR2000003019Huangshi Hospital of Traditional Chinese Medicine
Not yet recruiting
Phase 1
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high riskITMCTR2000003652Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Completed
Phase 3
A randomized, multicenter, controlled trial of the effectiveness of nebulized therapy with 3% hypertonic saline solution compared with 0.9% saline solution in hospitalized infants with RS viral bronchiolitis.RS viral bronchiolitisJPRN-UMIN000001700Tokyo Metropolitan Children's medical center Hospital120
Completed
Not Applicable
A multi-center, randomized, controlled trial on the efficacy and safety of metal stents for biliary drainage prior to pancreatic cancer surgerypancreatic cancerJPRN-UMIN000032076Juntendo University200
Active, not recruiting
Not Applicable
A multi-center, randomized, controlled trial with programmed introduction of Sirolimus-based, Calcineurin inhibitor free immunosuppression in recipients of non-heart-beating donor kidney grafts. - PRINS studyEUCTR2007-002763-27-NLErasmus MC